In addition, after stratifying participants by ApoE4 status, we found that chronic low-grade inflammation was significantly associated with AD risk only in ApoE4 carriers (hazard ratio, 4.70; 95% CI, 1.83-12.04; P = .001), but not in ApoE2 or ApoE3 carriers. This evidence concerns the gene APOE and Alzheimer disease.